Who gets to profit from Canada’s booming weed industry? Researchers at The Weekly found that nearly 40 former politicians and police officers are involved in medicinal marijuana companies, set to make retail sales as soon as it becomes legal.
Tag Archives: Politicians
Change is the only constant. Reflecting on the past seven years in the cannabis industry, I marvel at how much has changed and how quickly it has happened.
On Oct. 19, 2016, Gallup released its latest poll on marijuana legalization support in the United States, finding that public support is at 60%, a record-breaking percentage for legalization in Gallup’s 47-year polling history.
On Feb. 12, 2016, on “Real Time with Bill Maher,” host Bill Maher directed his “New Rules” editorial segment to proponents of marijuana legalization, reminding them that legalization is not guaranteed, even if it is recreationally legal in four states.
The European market continues to open with caution. This fall, widespread medical hemp and CBD availability made little international news when it went on sale in Europe, but movement is afoot even if it is proceeding slowly and without much fanfare.
The first candidate to address the question of legalization was Sen. Rand Paul, who has made a name for himself by championing hands-off governance.
As cannabis legalization efforts gain momentum, every effort should be made to package marijuana products in child-resistant packaging to keep them away from curious little hands.
Cannabis stocks started out the first trading day of the month with optimism. Are cannabis bulls returning to the space?
Welcome the 2014 MJINews Power Politicians. These are the 10 politicians who affect legislation for the legal marijuana industry, spanning federal, state and municipal jurisdictions.
CHICAGO, October 14, 2014 /Weed Wire/ — Meet the 2014 MJINews Power Players. These are the 10 movers and shakers that influence investment opportunities in the legal marijuana industry.
Meet the 2014 MJINews Power Players. These are the 10 movers and shakers that influence investment opportunities in the legal marijuana industry. Some are advocates. Others are not.
New York moved last week to join 22 states in legalizing medical marijuana for patients with a diverse array of debilitating ailments, encompassing epilepsy and cancer, Crohn’s disease and Parkinson’s. Yet there is no rigorous scientific evidence that marijuana effectively treats the symptoms of many of the illnesses for which states have authorized its use.